SOW
DSGN icon

State of Wyoming’s Design Therapeutics DSGN Stock Holding History

State of Wyoming’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.1K Buy
+2,566
New +$32K ﹤0.01% 1729
2022
Q3 		– Sell
-122
Closed -$2K – 1630
2022
Q2 		$2K Buy
122
+29
+31% +$392 ﹤0.01% 1776
2022
Q1 		$2K Buy
93
+16
+21% +$245 ﹤0.01% 1704
2021
Q4 		$2K Sell
77
-4
-5% -$69 ﹤0.01% 1771
2021
Q3 		$1K Sell
81
-40
-33% -$665 ﹤0.01% 1178
2021
Q2 		$2K Buy
+121
New +$3.05K ﹤0.01% 1116

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State of Wyoming's DSGN Position: Q2 2026 in Review

State of Wyoming opened a new position in Design Therapeutics (DSGN) in Q2 2026: 2,566 shares worth $37.1K. The stake represents ﹤0.01% of the portfolio and ranks #1729 among its holdings. This is a return to the name: State of Wyoming previously reported a position in DSGN as recently as Q2 2022.

State of Wyoming first reported a position in DSGN in Q2 2021 and has held it in 6 quarters since. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • State of Wyoming held 2,566 shares of Design Therapeutics worth $37.1K as of Q2 2026.
  • Design Therapeutics was a new State of Wyoming position in Q2 2026.
  • Design Therapeutics made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1729 holding.
  • State of Wyoming first reported a position in Design Therapeutics in Q2 2021 and has held it in 6 quarters since.
  • 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.